Peakdale

Peakdale Molecular is a premier UK-based contract research organization (CRO) specializing in drug discovery chemistry and chemical synthesis services. Founded in 1992, the company provides expertise in medicinal chemistry, custom synthesis, and process research and development to global pharmaceutical and biotechnology partners. Known for its problem-solving capabilities in complex molecular assembly, Peakdale supports projects from early-stage hit identification through to lead optimization. In 2014, the company was acquired to become a core component of the Concept Life Sciences group, integrating its chemistry strengths with broader analytical and biological services. Today, its legacy continues as a key part of the Concept Life Sciences drug discovery platform, operating out of major research hubs in the United Kingdom.